About the journal
Frontiers in Tuberculosis is an open-access journal published by Frontiers Media S.A. in Switzerland, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 1,950 CHF. Declared review time at DOAJ: 12 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Frontiers Media S.A.
- ISSN
- 2813-7868
- Country
- Switzerland
- Languages
- english
- Access
- Open access
- Declared publication charge
- 1,950 CHF
- Articles in DOAJ
- 29
- Declared review time
- 12 weeks
- Declared peer-review model
- peer_review
- Official website
- https://www.frontiersin.org/journals/tuberculosis
Index listings
- DOAJ · 2024-11-02
- Indexing
- DOAJ
- APC
- 1,950 CHF
- Declared review time (DOAJ)
- 12 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
29
Most recent article
2 months ago
Average review time (journal-declared via DOAJ)
12weeks
Works in OpenAlex
69
Last recorded publication year
2026
h-index
5
i10-index
3
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2025-05-13
- Added to DOAJ
- 2024-11-02
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSS
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSS
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 99%
- ORCID iDs in current deposits
- 0%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 9918697582306676
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Tuberculosis Research and Epidemiology
- Tuberculosis Research and Epidemiology
- Mycobacterium research and diagnosis
- Mycobacterium research and diagnosis
- Pneumonia and Respiratory Infections
- Diagnosis and treatment of tuberculosis
- Pneumonia and Respiratory Infections
- Diagnosis and treatment of tuberculosis
Show all subjects (50)
- Infectious Diseases and Tuberculosis
- Infectious Diseases and Tuberculosis
- Immune responses and vaccinations
- Immune responses and vaccinations
- Pneumocystis jirovecii pneumonia detection and treatment
- Pneumocystis jirovecii pneumonia detection and treatment
- Immunodeficiency and Autoimmune Disorders
- Bacterial Genetics and Biotechnology
- Immunodeficiency and Autoimmune Disorders
- Bacterial Genetics and Biotechnology
- vaccines and immunoinformatics approaches
- Chronic Disease Management Strategies
- Health Policy Implementation Science
- vaccines and immunoinformatics approaches
- Chronic Disease Management Strategies
- Health Policy Implementation Science
- Healthcare Facilities Design and Sustainability
- Extracellular vesicles in disease
- Helicobacter pylori-related gastroenterology studies
- Healthcare Facilities Design and Sustainability
- Cell Image Analysis Techniques
- Metabolism and Genetic Disorders
- Extracellular vesicles in disease
- Cystic Fibrosis Research Advances
- Misinformation and Its Impacts
- Antibiotic Resistance in Bacteria
- Antibiotic Resistance in Bacteria
- Cell Image Analysis Techniques
- Metabolism and Genetic Disorders
- Healthcare Systems and Reforms
- Invertebrate Immune Response Mechanisms
- Invertebrate Immune Response Mechanisms
- Cystic Fibrosis Research Advances
- Healthcare Systems and Reforms
- Helicobacter pylori-related gastroenterology studies
- Misinformation and Its Impacts
- MicroRNA in disease regulation
- Malaria Research and Control
- HIV/AIDS Research and Interventions
- HIV/AIDS Research and Interventions
- Malaria Research and Control
- MicroRNA in disease regulation
Keywords (DOAJ)
- tuberculosis
- mycobacterium
- epidemiology
- immunology
- therapeutics
- diagnostics
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ